Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I agree Great Marketing. Lets see some Green Today. Hopefully we'll get some attention during 10 and 11 am :D
GLTA
Good Market Strategy. Start with much better Company name to fit the product and new share structure in place and plan for current status and transparency @ OTC-P. Go on a Market news radio show with Bill Chippas to advertise the product before production and take questions too. FDA approved, All ducks in a row and the horse before the cart! Excellent new start to Pharmstar Pharmaceuticals, Inc. IMO.
A lot of people like and use liquid otc meds and they have been around a long time. This product is target specific/multi flavored and I believe it will do well on the market.
PHAR NEWS OUT $ CEO to Appear on the Bill Chippas Show on Tuesday, April 12, 2011, which airs between 10:00 am to 11:00 am Eastern Time
New Pharmstar Pharmaceuticals IHub Board is @
http://investorshub.advfn.com/boards/board.aspx?board_id=6832
Company Info Updated...
Share Structure
Market Value1 $304,558 a/o Apr 07, 2011
Shares Outstanding 998,879,352 a/o Apr 08, 2011
Float 12,455,853 a/o Apr 08, 2011
Authorized Shares 1,001,184,352 a/o Apr 05, 2011
Par Value 0.01
Shareholders
Shareholders of Record 903 a/o Dec 31, 2010
http://www.otcmarkets.com/stock/PHAR/company-info
Agree. Talk about recycling the old and washed out.. Tommy Johnson was a DM puppet way back in the day... History appears to be coming round the corner as you say...
If it has Tommy Johnson or Christopher "Kit" Chambers associated with it, then look out folks... history is in the process of repeating itself, but it brings with it nothing SHORT of opportunity...
Words to the not so wise...
Go PHAR! $$
I agree with you vlad, Ive done my dd :)
PHARMANETICS, INC. IS DISSOLVED! as it says in your boards info.
Go to Pharmstar Pharmaceuticals, Inc. (PHAR) board to discuss the new PHAR. The BMGI stocks will convert to PHAR and PHARMANETICS, INC. shares are gone, not worth anything.
Pharmstar Pharmaceuticals Board is http://investorshub.advfn.com/boards/board.aspx?board_id=6832
PS the new PHAR has great potential, check it out, and do a little DD.
GLTA
Vlad
It typically takes 3-5 business days before your symbol BMGI will be changed to PHAR. It varies from company to company.
My account grabs the PHAR share price
When look up BMGI on my Ameritrade account, I receive the message "no symbol found"
Nothing, it lets me preview for both...
There are two Co. PHAR !!!!! same price or No ?
what happens if you preview the sale?
Yes, and they still show up in my tdameritrade account as bmgi :(
I hope they convert..
Im pretty sure that they convert into PHAR. However I am not definite on this. Are you holding BMGI shares?
So, I am a bit confused. What happens to those people who are holding BMgI shares. They become phar or they lose everything?
indeed. GLT US :D $$
It will run big!! I can see them in high cents (.50+) in the coming days>>> Lets hope for the best $$$$$
Some buying pressure and this should take off
Ok Everyone Lets get this PHAR going !!
GLTA
just testing my picture posting on a dead board...
Were you just stopping by to visit the grave site? :) PHAR...R.I.P.
Well we had some nice Pharties along the way! LOL
PharmaNetics 7/27/1998 - 1/9/2009 Rest In Peace!
Hopefully we will have better luck with our other shells.
I want to know how theshares were still trading in a dissolved company!!!??????
Who knew that the company was actually dissolved on October 31, 2008?
What is a trader to do, check with the SOS every few days?
And this fact did not hit the Daily list until 1/8/2008?
Low rent!
Select this:
11/3/2008 C200830500353 DISS - Articles of Dissolution
On this page:
http://www.secretary.state.nc.us/corporations/Filings.aspx?PItemId=4796524
NC SOS - Dissolved
http://www.secretary.state.nc.us/corporations/Corp.aspx?PitemId=4796524
This is a snippet from a plan of Dissolution of another company. In this particular case the commons get something.
Hi guy,,, Happy New Year!!! .. Put these on yuor list... No-Brainers... XYTS, THMR, MRNA, CNTO, QI .. I got a mess in all, but XYTS THMR MRNA, is going to run big, CNTO is a holder with Mega potential, and QI has a GOOD Shoot.. I goin in at .06, out at .54 with 50K Could go back down to the .20's for another pop.l Best Bet though is XYTS and MRNA,. CNTO is a Nie Shell with some nice name assocated with them.. Check iot out.. Would lose.
Mike
Scottrade did not show anything abnormal.
Dam.
On the daily list from 1/8/2009 it's there under the header:
SECURITY DELETIONS
14:07 PHAR PharmaNetics, Inc. Common Stock 1/9/2009 100 Plan of Dissolution **
I don't even remember this filing for bankruptcy
I'm not done looking but I sure have found the following phrase used when talking about dissolution, "dissolution proceeds".
I like that phrase!
No, I didn't find a link. I'm just assuming that it has been revoked.
it's like a lottery, not alot are getting revoked imho
Did you find a link that says we are revoked?
This is the kind of stuff is what I would have expected to see if we are revoked:
This is the 4th revoked stock that I will have to write off now! I wonder which other of my shells are next?
what happened?
You'd think that with that entry on the Daily list, there would be something that the motoring public could see in filing form.
by bye phar? where'd she go? lol
The cupboard, she looks bare!
whats the deal? have a few hundred k of this puppy still?
I am very busy and would appreciate any DD help here! Thanks!
That has got to be the company shutting down, not necessarily being delisted or revoked.
Problem is, where is the plan displayed?
Well it don't look good for the home team!
It looks so man
Followers
|
18
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
1086
|
Created
|
06/01/06
|
Type
|
Free
|
Moderators |
PHARMANETICS, INC. IS DISSOLVED!
Name | Name Type | ||
PHARMANETICS, INC. | Legal | ||
Business Corporation Information | |||
SOSID: | 0465625 | ||
Status: | Dissolved | ||
Date Formed: | 7/27/1998 | ||
Citizenship: | Domestic | ||
State of Inc.: | NC | ||
Duration: | Perpetual | ||
Registered Agent | |||
Agent Name: | Robbins, Larry E. | ||
Registered Office Address: | 4101 Lake Boone Trail Suite 300 Raleigh NC 27607 | ||
Registered Mailing Address: | P O Box 5036 Cary NC 27512 | ||
Principal Office Address: | 9401 Globe Center Dr Ste 140 Morrisville NC 27560 | ||
Principal Mailing Address: | P O Box 5036 Cary NC 27512 |
Stock | ||||
Class | Shares | No Par Value | Par Value | |
Common | 40000000 | Yes | N/A | |
Preferred | 750000 | Yes | N/A | |
Preferred A | 120000 | Yes | N/A | |
Preferred B | 130000 | Yes | N/A |
05/13/2005 (16:48 ET) PHAR: Filed New Form 15-12G
Authorized Shares: 40,000,000
FEBRUARY 20, 2008 UPDATE
Shares Float
Total Shares Outstanding 10,604,517
% Owned by Insiders %
% Owned by Institutions %
Market Cap. 37,116
Trading Volume - Today 530,000
Trading Volume - Average 128,200
Trading Volume - Today vs. Average 413.42 %
Earnings Per Share -0.79
PE Ratio
Record Date 2008-Feb
Funkhouser is still in control of this empty shell according to NC SOS site. The pharmanetics website is gone. He's also the president of nContact Surgical.
http://www.ncontact.us/company/index.shtml
There are some small VCs listed, could they be buying up the shares before they announce a RM? PHAR seems like a clean shell.
DELAYED LEVEL II http://66.201.236.134/export/level2.jsp?symbol=phar
-----------------------------------------------------------
Southeast Texas business in brief
Sunday , July 23, 2006 06:16ET
Jul 23, 2006 (The Beaumont Enterprise - Knight Ridder/Tribune Business News via COMTEX) -- Drug company will create 50 local jobs
BEAUMONT -- Helena Laboratories, 1530 Lindbergh Drive, said it acquired the products and technology of PharmaNetics Inc., of Morrisville, N.C., and will move its operations to Beaumont, creating 50 jobs during the next two years.
Terms of the acquisition were not disclosed.
The new products will expand Helena's Point of Care division, which includes products for blood platelet function screening and activated clotting time-testing.
PharmaNetics developed a dry chemistry system that is used to rapidly assess blood-clot formation and dissolution for patients where they are receiving care.
The products help in treatment of angina, heart attack, stroke, and lung embolisms.
Helena, founded in 1966, will market the products under the name "Cascade POC."
----------------------------------------------------------
FROM PRE 14A 5/19/05 http://www.secinfo.com/d14D5a.z288f.htm
Purchase Price for Assets; Distribution of Net Cash Received Pursuant to Asset Sale Plan
The purchase price for the assets to be sold pursuant to the Asset Sale Plan will be negotiated by our management at arms-length with the party or parties that desire to acquire some or all of the assets. Management will consult with such financial, legal and other advisors as they deem appropriate in these negotiations. To the extent material and as may be required by applicable law, the final purchase price and other material terms of any actual sale of assets pursuant to the Asset Sale Plan will be approved by the Board of Directors.
Within 12 months of the closing of the final sale of assets pursuant to the Asset Sale Plan, we are required to distribute to our shareholders the cash we received in the sale of the assets, if any, net of expenses incurred in connection with the sale (including the fees and expenses of our legal, financial and other advisors) and net of any amounts that may be payable to our creditors or pursuant to other contractual or other obligations. In the event any cash from the sale of assets are held in escrow or otherwise encumbered for more than 12 months following the closing of a sale, we will promptly distribute such encumbered cash as soon as it is released to us. If we receive any property other than cash in connection with the sale of assets under the Asset Sale Plan, our management will liquidate such assets for cash in a manner designed, in their discretion, to maximize the cash to be distributed to our shareholders.
Any cash we receive as a result of the sale of assets under the Asset Sale Plan will be available for distribution to our shareholders in accordance with the priorities and preferences set forth in our Articles of Incorporation. Our Articles of Incorporation provide that, prior to the distribution of any such cash to the holders of our common stock, the holders of our Series A and Series B preferred stock shall first receive their full senior liquidation preference. As of the date hereof, the aggregate liquidation preference payable to the holders of our Series A and Series B preferred stock was approximately $17.8 million. Given the nature and estimated value of these assets and in light of the fact that we ceased substantially all of our operations in March 2004, management considers it highly unlikely that the net cash to be distributed to our shareholders, if any, from any sale of these assets will exceed the liquidation preference payable to holders of our Series A and Series B Preferred stock. As a result, the holders of our common stock will likely not be in a position to receive any cash distributions as a result of the sale of the assets pursuant to the Asset Sale Plan, and the holders of our Series A and Series B preferred stock might receive only a small fraction of the full liquidation preference that they are entitled to under our Articles of Incorporation. Because we do not expect to realize substantial proceeds, if any, from the sale of our remaining assets, management believes that perhaps the only meaningful opportunity for a distribution to shareholders would be as a result of the receipt of a sizeable recovery by PharmaNetics in its litigation against Aventis. There can, however, be no assurance that PharmaNetics will prevail in this litigation or that the amount of any recovery would provide significant available proceeds for distribution to the shareholders.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |